• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

高危前列腺癌高剂量率调强近距离放疗联合外照射放疗的长期生化结果。

Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer.

机构信息

Department of Radiation Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain.

出版信息

Radiat Oncol. 2012 Mar 7;7:31. doi: 10.1186/1748-717X-7-31.

DOI:10.1186/1748-717X-7-31
PMID:22397528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3310720/
Abstract

Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.The treatment regimen of HDR brachytherapy and external beam radiotherapy is a safe and very effective treatment for patients with high risk localized prostate cancer with excellent biochemical control and low toxicity.

摘要

对于接受不利前列腺癌和/或低剂量外照射放疗的患者进行根治性前列腺切除术的系列研究中，生化控制仍然不理想。对于高危局限性前列腺癌患者，HDR 近距离放疗和外照射放疗的治疗方案是一种安全且非常有效的治疗方法，具有出色的生化控制和低毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/51986936e6c7/1748-717X-7-31-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/c410adc5a6a3/1748-717X-7-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/2b05975d1cae/1748-717X-7-31-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/d0493f3bf282/1748-717X-7-31-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/51986936e6c7/1748-717X-7-31-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/c410adc5a6a3/1748-717X-7-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/2b05975d1cae/1748-717X-7-31-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/d0493f3bf282/1748-717X-7-31-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d6/3310720/51986936e6c7/1748-717X-7-31-4.jpg

相似文献

1
Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer.高危前列腺癌高剂量率调强近距离放疗联合外照射放疗的长期生化结果。
Radiat Oncol. 2012 Mar 7;7:31. doi: 10.1186/1748-717X-7-31.
2
Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.使用调强放射治疗、三维适形放射治疗、永久性植入近距离放射治疗和高剂量率近距离放射治疗对前列腺癌放疗的急性和亚急性泌尿生殖系统及胃肠道不良事件进行比较。
Tumori. 2014 May-Jun;100(3):265-71. doi: 10.1700/1578.17198.
3
Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 years of experience.高剂量率调强近距离放疗联合外照射放疗的生化疗效：12 年经验。
BJU Int. 2012 Jun;109(12):1787-93. doi: 10.1111/j.1464-410X.2011.10632.x. Epub 2011 Oct 7.
4
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes.外照射放疗、高剂量率近距离放疗联合长期雄激素剥夺治疗在高危和极高危前列腺癌中的剂量递增：两种连续高剂量率方案的比较
Brachytherapy. 2016 Mar-Apr;15(2):127-35. doi: 10.1016/j.brachy.2015.12.008. Epub 2016 Jan 29.
5
Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.局限性前列腺癌男性患者中，根治性前列腺切除术、外照射放疗、近距离放疗或主动监测的选择与患者报告的生活质量之间的关联。
JAMA. 2017 Mar 21;317(11):1141-1150. doi: 10.1001/jama.2017.1652.
6
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer.≥75 岁局限性前列腺癌男性患者接受高剂量率近距离放疗联合外照射放疗后的毒性和危险因素。
Strahlenther Onkol. 2019 May;195(5):374-382. doi: 10.1007/s00066-018-1380-5. Epub 2018 Nov 2.
7
A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients.高剂量率近距离放疗联合低分割外照射放疗可使局限性中高危前列腺癌患者获得较高的无生化复发生存率。
Radiother Oncol. 2016 Nov;121(2):299-303. doi: 10.1016/j.radonc.2016.09.016. Epub 2016 Oct 28.
8
Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.使用分期淋巴结清扫术联合适形高剂量率铱-192近距离放射治疗和外照射放疗对局限性前列腺癌进行综合治疗的临床结果。
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):684-90. doi: 10.1016/j.ijrobp.2003.11.035.
9
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.调强放疗联合近距离放疗治疗前列腺癌时，其副作用比三维适形放疗少。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16.
10
Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer.采用适形高剂量率近距离放射疗法进行剂量递增可改善预后不良的前列腺癌的治疗效果。
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):316-27. doi: 10.1016/s0360-3016(02)02733-5.

引用本文的文献

1
Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer.高危局限性前列腺癌高剂量率近距离放疗联合外照射放疗而不采用激素治疗的长期疗效。
Jpn J Radiol. 2024 Nov;42(11):1322-1329. doi: 10.1007/s11604-024-01621-4. Epub 2024 Jun 29.
2
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis.局限性前列腺癌外照射放疗后每两周一次的高剂量率近距离放疗增敏：长期疗效及毒性分析
Front Oncol. 2021 Nov 26;11:764536. doi: 10.3389/fonc.2021.764536. eCollection 2021.
3

本文引用的文献

1
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.根治性前列腺切除术后高危前列腺癌患者的病理结果和治疗失败率。
BJU Int. 2011 Mar;107(5):765-770. doi: 10.1111/j.1464-410X.2010.09594.x. Epub 2010 Sep 28.
2
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.高危前列腺癌患者接受近距离放射治疗、外照射放射治疗和激素治疗联合治疗的结果。
BJU Int. 2009 Dec;104(11):1631-6. doi: 10.1111/j.1464-410X.2009.08661.x. Epub 2009 Jun 2.
3
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies.
High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.
高剂量率近距离放射治疗前列腺癌：原理、当前应用和临床结果。
Cancer Rep (Hoboken). 2022 Jan;5(1):e1450. doi: 10.1002/cnr2.1450. Epub 2021 Jun 23.
4
The evolution of brachytherapy for prostate cancer.前列腺癌近距离治疗的演变。
Nat Rev Urol. 2017 Jun 30;14(7):415-439. doi: 10.1038/nrurol.2017.76.
5
American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review.美国近距离放射治疗学会任务组报告：雄激素剥夺疗法联合前列腺近距离放射治疗的应用——系统文献综述
Brachytherapy. 2017 Mar-Apr;16(2):245-265. doi: 10.1016/j.brachy.2016.11.017. Epub 2017 Jan 16.
6
Clinical management and burden of prostate cancer: a Markov Monte Carlo model.前列腺癌的临床管理与负担：马尔可夫蒙特卡罗模型
PLoS One. 2014 Dec 4;9(12):e113432. doi: 10.1371/journal.pone.0113432. eCollection 2014.
7
Radiation dose to rectum in high-dose-rate brachytherapy with a single implant and two fractions for prostate cancer, and its prediction by prostate volume.前列腺癌单次植入及两次分割高剂量率近距离放疗时直肠的辐射剂量及其与前列腺体积的相关性
Radiol Phys Technol. 2015 Jan;8(1):18-25. doi: 10.1007/s12194-014-0281-2. Epub 2014 Jul 18.
8
The status of surgery in the management of high-risk prostate cancer.高危前列腺癌的外科治疗现状。
Nat Rev Urol. 2014 Jun;11(6):342-51. doi: 10.1038/nrurol.2014.100. Epub 2014 May 13.
9
Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes.高剂量率近距离放疗用于前列腺癌治疗：三种不同分割方案的早期毒性分析
J Contemp Brachytherapy. 2013 Dec;5(4):203-9. doi: 10.5114/jcb.2013.38657. Epub 2013 Oct 31.
10
High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up.高剂量率近距离放疗与大分割外照射放疗联合长期激素治疗高危和极高危前列腺癌：5年随访结果
J Radiat Res. 2014 May;55(3):509-17. doi: 10.1093/jrr/rrt128. Epub 2013 Nov 11.
耻骨后、腹腔镜及机器人辅助根治性前列腺切除术：比较研究的系统评价与累积分析
Eur Urol. 2009 May;55(5):1037-63. doi: 10.1016/j.eururo.2009.01.036. Epub 2009 Jan 25.
4
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.MD安德森前列腺癌随机剂量递增试验的长期结果。
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74. doi: 10.1016/j.ijrobp.2007.06.054. Epub 2007 Aug 31.
5
Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.经会阴在直肠前脂肪中注射透明质酸，以降低前列腺癌患者接受调强近距离放疗或外照射放疗时直肠的放射性毒性。
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):95-102. doi: 10.1016/j.ijrobp.2007.02.034.
6
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.针对具有中高危特征的前列腺癌患者，采用近距离放射治疗和补充适形放疗后的长期疗效。
Cancer. 2007 Aug 1;110(3):551-5. doi: 10.1002/cncr.22810.
7
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.对于临床局限性前列腺癌男性患者，在接受或未接受激素治疗的情况下，定义放疗后的生化复发：美国放射肿瘤学组（RTOG）-美国放射肿瘤学会（ASTRO）凤凰城共识会议的建议
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74. doi: 10.1016/j.ijrobp.2006.04.029.
8
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.局部晚期前列腺癌的短期雄激素剥夺与放疗：跨塔斯曼放射肿瘤学组96.01随机对照试验的结果
Lancet Oncol. 2005 Nov;6(11):841-50. doi: 10.1016/S1470-2045(05)70348-X.
9
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.传统剂量与高剂量适形放射治疗在临床局限性前列腺腺癌中的比较：一项随机对照试验。
JAMA. 2005 Sep 14;294(10):1233-9. doi: 10.1001/jama.294.10.1233.
10
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.前列腺癌根治性放疗辅助雄激素抑制——RTOG 85-31 Ⅲ期试验的长期结果
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1285-90. doi: 10.1016/j.ijrobp.2004.08.047.